2003
DOI: 10.1016/s0169-409x(02)00223-5
|View full text |Cite
|
Sign up to set email alerts
|

Lab-on-a-chip for drug development

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
249
0
5

Year Published

2006
2006
2013
2013

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 435 publications
(254 citation statements)
references
References 170 publications
0
249
0
5
Order By: Relevance
“…Lab-on-a-Chip) is a key enabling technology for point-of-care diagnostics as it promises improvements over standard immunoassay formats in terms of speed, sensitivity and reagent consumption, and can potentially be highly automated [11][12][13][14][15][16][17][18][19][20] . A low-cost disposable microfluidic card could, in principle, carry out the necessary tests using a small patient sample and a scant amount of expensive reagents, (such as antibodies).…”
Section: Microfluidics (And Its Integration Into What Is Known Asmentioning
confidence: 99%
“…Lab-on-a-Chip) is a key enabling technology for point-of-care diagnostics as it promises improvements over standard immunoassay formats in terms of speed, sensitivity and reagent consumption, and can potentially be highly automated [11][12][13][14][15][16][17][18][19][20] . A low-cost disposable microfluidic card could, in principle, carry out the necessary tests using a small patient sample and a scant amount of expensive reagents, (such as antibodies).…”
Section: Microfluidics (And Its Integration Into What Is Known Asmentioning
confidence: 99%
“…The creation and integration of these components represents a more substantial problem than it might seem, but the development of new microfluidic elements, and means to incorporate them into devices, are proceeding. Systems for bioanalysis and separation, [1][2][3] or high-throughput screening 4,5 are already available. We are especially interested in devices to be used in resource poor environments-e.g., in healthcare in developing countries, by first responders and the military, and in analogous problems-where portability and ruggedness are key concerns.…”
Section: Introductionmentioning
confidence: 99%
“…addressable delivery systems for charged biomolecules. We envisage that such ionic circuits will have impact in various fields including sensors 25 , lab-on-a-chip 26 , drug delivery 27 and electrochemical components 28 .…”
mentioning
confidence: 99%